Compile Data Set for Download or QSAR
Report error Found 21 Enz. Inhib. hit(s) with all data for entry = 6386
TargetDisintegrin and metalloproteinase domain-containing protein 33(Human)
Galderma Research & Development

US Patent
LigandPNGBDBM125925(US8772478, 14)
Affinity DataIC50: 24nMpH: 7.4Assay Description:The products are solubilized in DMSO at a concentration of 10 mM. A serial 3-fold dilution over 10 points is carried out so as to have a concentratio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2014
Entry Details
Go to US Patent

TargetDisintegrin and metalloproteinase domain-containing protein 33(Human)
Galderma Research & Development

US Patent
LigandPNGBDBM125923(US8772478, 15 | US8772478, 8)
Affinity DataIC50: 26nMpH: 7.4Assay Description:The products are solubilized in DMSO at a concentration of 10 mM. A serial 3-fold dilution over 10 points is carried out so as to have a concentratio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2014
Entry Details
Go to US Patent

TargetDisintegrin and metalloproteinase domain-containing protein 33(Human)
Galderma Research & Development

US Patent
LigandPNGBDBM125925(US8772478, 14)
Affinity DataIC50: 38nMpH: 7.4Assay Description:The products are solubilized in DMSO at a concentration of 10 mM. A serial 3-fold dilution over 10 points is carried out so as to have a concentratio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2014
Entry Details
Go to US Patent

TargetDisintegrin and metalloproteinase domain-containing protein 33(Human)
Galderma Research & Development

US Patent
LigandPNGBDBM125923(US8772478, 15 | US8772478, 8)
Affinity DataIC50: 112nMpH: 7.4Assay Description:The products are solubilized in DMSO at a concentration of 10 mM. A serial 3-fold dilution over 10 points is carried out so as to have a concentratio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2014
Entry Details
Go to US Patent

TargetDisintegrin and metalloproteinase domain-containing protein 33(Human)
Galderma Research & Development

US Patent
LigandPNGBDBM125922(US8772478, 7)
Affinity DataIC50: 147nMpH: 7.4Assay Description:The products are solubilized in DMSO at a concentration of 10 mM. A serial 3-fold dilution over 10 points is carried out so as to have a concentratio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2014
Entry Details
Go to US Patent

TargetDisintegrin and metalloproteinase domain-containing protein 33(Human)
Galderma Research & Development

US Patent
LigandPNGBDBM125917(US8772478, 1)
Affinity DataIC50: 181nMpH: 7.4Assay Description:The products are solubilized in DMSO at a concentration of 10 mM. A serial 3-fold dilution over 10 points is carried out so as to have a concentratio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2014
Entry Details
Go to US Patent

TargetDisintegrin and metalloproteinase domain-containing protein 33(Human)
Galderma Research & Development

US Patent
LigandPNGBDBM125919(US8772478, 3)
Affinity DataIC50: 181nMpH: 7.4Assay Description:The products are solubilized in DMSO at a concentration of 10 mM. A serial 3-fold dilution over 10 points is carried out so as to have a concentratio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2014
Entry Details
Go to US Patent

TargetDisintegrin and metalloproteinase domain-containing protein 33(Human)
Galderma Research & Development

US Patent
LigandPNGBDBM125920(US8772478, 5)
Affinity DataIC50: 249nMpH: 7.4Assay Description:The products are solubilized in DMSO at a concentration of 10 mM. A serial 3-fold dilution over 10 points is carried out so as to have a concentratio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2014
Entry Details
Go to US Patent

TargetDisintegrin and metalloproteinase domain-containing protein 33(Human)
Galderma Research & Development

US Patent
LigandPNGBDBM125918(US8772478, 2)
Affinity DataIC50: 298nMpH: 7.4Assay Description:The products are solubilized in DMSO at a concentration of 10 mM. A serial 3-fold dilution over 10 points is carried out so as to have a concentratio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2014
Entry Details
Go to US Patent

TargetDisintegrin and metalloproteinase domain-containing protein 33(Human)
Galderma Research & Development

US Patent
LigandPNGBDBM125921(US8772478, 6)
Affinity DataIC50: 328nMpH: 7.4Assay Description:The products are solubilized in DMSO at a concentration of 10 mM. A serial 3-fold dilution over 10 points is carried out so as to have a concentratio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2014
Entry Details
Go to US Patent

TargetDisintegrin and metalloproteinase domain-containing protein 33(Human)
Galderma Research & Development

US Patent
LigandPNGBDBM125924(US8772478, 9)
Affinity DataIC50: 469nMpH: 7.4Assay Description:The products are solubilized in DMSO at a concentration of 10 mM. A serial 3-fold dilution over 10 points is carried out so as to have a concentratio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2014
Entry Details
Go to US Patent

TargetInterstitial collagenase(Human)
Galderma Research & Development

US Patent
LigandPNGBDBM125923(US8772478, 15 | US8772478, 8)
Affinity DataIC50: 1.98E+3nMpH: 7.4Assay Description:The products are solubilized in DMSO at a concentration of 10 mM. A serial 3-fold dilution over 10 points is carried out so as to have a concentratio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2014
Entry Details
Go to US Patent

TargetInterstitial collagenase(Human)
Galderma Research & Development

US Patent
LigandPNGBDBM125923(US8772478, 15 | US8772478, 8)
Affinity DataIC50: 3.00E+3nMpH: 7.4Assay Description:The products are solubilized in DMSO at a concentration of 10 mM. A serial 3-fold dilution over 10 points is carried out so as to have a concentratio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2014
Entry Details
Go to US Patent

TargetStromelysin-1(Human)
Galderma Research & Development

US Patent
LigandPNGBDBM125925(US8772478, 14)
Affinity DataIC50: 3.03E+3nMpH: 7.4Assay Description:The products are solubilized in DMSO at a concentration of 10 mM. A serial 3-fold dilution over 10 points is carried out so as to have a concentratio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2014
Entry Details
Go to US Patent

TargetStromelysin-1(Human)
Galderma Research & Development

US Patent
LigandPNGBDBM125923(US8772478, 15 | US8772478, 8)
Affinity DataIC50: 4.50E+3nMpH: 7.4Assay Description:The products are solubilized in DMSO at a concentration of 10 mM. A serial 3-fold dilution over 10 points is carried out so as to have a concentratio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2014
Entry Details
Go to US Patent

TargetMatrix metalloproteinase-9(Human)
Galderma Research & Development

US Patent
LigandPNGBDBM125923(US8772478, 15 | US8772478, 8)
Affinity DataIC50: 1.00E+4nMpH: 7.4Assay Description:The products are solubilized in DMSO at a concentration of 10 mM. A serial 3-fold dilution over 10 points is carried out so as to have a concentratio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2014
Entry Details
Go to US Patent

TargetMatrix metalloproteinase-9(Human)
Galderma Research & Development

US Patent
LigandPNGBDBM125925(US8772478, 14)
Affinity DataIC50: 1.00E+4nMpH: 7.4Assay Description:The products are solubilized in DMSO at a concentration of 10 mM. A serial 3-fold dilution over 10 points is carried out so as to have a concentratio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2014
Entry Details
Go to US Patent

TargetDisintegrin and metalloproteinase domain-containing protein 9(Human)
Galderma Research & Development

US Patent
LigandPNGBDBM125923(US8772478, 15 | US8772478, 8)
Affinity DataIC50: 1.00E+4nMpH: 7.4Assay Description:The products are solubilized in DMSO at a concentration of 10 mM. A serial 3-fold dilution over 10 points is carried out so as to have a concentratio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2014
Entry Details
Go to US Patent

TargetDisintegrin and metalloproteinase domain-containing protein 9(Human)
Galderma Research & Development

US Patent
LigandPNGBDBM125925(US8772478, 14)
Affinity DataIC50: 1.00E+4nMpH: 7.4Assay Description:The products are solubilized in DMSO at a concentration of 10 mM. A serial 3-fold dilution over 10 points is carried out so as to have a concentratio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2014
Entry Details
Go to US Patent

TargetDisintegrin and metalloproteinase domain-containing protein 10(Human)
Galderma Research & Development

US Patent
LigandPNGBDBM125923(US8772478, 15 | US8772478, 8)
Affinity DataIC50: 1.00E+4nMpH: 7.4Assay Description:The products are solubilized in DMSO at a concentration of 10 mM. A serial 3-fold dilution over 10 points is carried out so as to have a concentratio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2014
Entry Details
Go to US Patent

TargetDisintegrin and metalloproteinase domain-containing protein 10(Human)
Galderma Research & Development

US Patent
LigandPNGBDBM125925(US8772478, 14)
Affinity DataIC50: 1.00E+4nMpH: 7.4Assay Description:The products are solubilized in DMSO at a concentration of 10 mM. A serial 3-fold dilution over 10 points is carried out so as to have a concentratio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2014
Entry Details
Go to US Patent